Drs. Roma Chilengi and Caroline Chisenga

Photo of blog authors
Oct 10, 2019
While surely all researchers are excited when they initiate a new clinical trial, we are feeling particularly energized about a Phase 3 study that we started here in Zambia this week. It is the first efficacy study for a new type of rotavirus